INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.600
+0.070 (4.58%)
At close: Oct 29, 2026, 4:00 PM EDT
1.595
-0.005 (-0.31%)
Pre-market: Oct 30, 2026, 6:23 AM EDT
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $49.21 million as of October 29, 2026. It is the 30,175th most valuable company in the world and the 4,626th biggest in the United States. Its market cap has increased by 1.70% in one year.
Market Cap
49.21M
Enterprise Value
32.20M
1-Year Change
1.70%
Global Rank
Country Rank
#4,626 United States
Category
ChartMarket Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $49.21M, a decrease of -36.77%. That is a compound annual growth rate of -5.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 49.21M | 18.65% |
| Dec 31, 2025 | 41.47M | -59.95% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Instil Bio | 46.39M |
| Biomea Fusion | 46.37M |
| Apollomics | 46.01M |
| Actinium Pharmaceuticals | 45.90M |
| ImageneBio | 45.58M |
| Serina Therapeutics | 44.70M |
| Dogwood Therapeutics | 44.19M |
| Annovis Bio | 43.46M |